Pharmacokinetic/Pharmacodynamic and Safety Evaluation of Intravenous Peramivir in Children With Influenza

NCT01063933 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

NIH

Sponsor class

Conditions

Influenza

Interventions

DRUG: Peramivir

Sponsor

National Institute of Allergy and Infectious Diseases (NIAID)